IPO Boutique

Avalyn Pharma Inc. IPO Advisory

Share this IPO Profile:

Smart Search
Company begins with...
Company contains...

For IPO Boutique's "scale of 1 to 5" BUY rating on Avalyn Pharma Inc., and our comprehensive analysis, click "Buy Market Research".
Company
Symbol
Price Range
Issue Price
Open
Shares
Trade Date
Avalyn Pharma Inc.AVLN -
NASDAQ
$16.00-$18.00 $18.00 $26.0016.7 million4/30/2026
Morgan Stanley, Jefferies, Evercore ISI, Guggenheim Securities
Co-Manager(s):
Health Care
Filing(s):

Filed 2026-04-08
Terms Added 2026-04-23
Amended Terms 2026-04-29



Avalyn Pharma Inc. Quote & Chart - Click for current quote - AVLN

About Avalyn Pharma Inc. (adapted from Avalyn Pharma Inc. prospectus):
They are a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases with significant unmet needs.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.



IPO Boutique aggregates information on public companies and private companies, such as "AVLN" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.

Used our Comprehensive Single Promo Advisory and want more?
We also offer a monthly or annual subscription






© 2005 - 2026 IPO Boutique. All Rights Reserved